Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion The deal is a bet on the growing market for psychiatric and neurological drugs. Author: Lauren Hirsch Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to email a link to a friend (Opens in new window)Click to print (Opens in new window)MoreClick to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Tumblr (Opens in new window)
